Beta

Meiragtx holdings plcMGTX.US Overview

US StockHealthcare
(No presentation for MGTX)
OverviewAI AnalysisFinancialsFinancial ForecastStock SentimentalInstitutionsTradingView Chart

Ticker

Value

empty

There is no following symbol in this watchlist.

MGTX AI Insights

MGTX Overall Performance

MGTX AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

MGTX Recent Performance

-0.55%

Meiragtx holdings plc

-1.10%

Avg of Sector

-0.49%

S&P500

MGTX PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

Check MGTX's Trend

MGTX Key Information

MGTX Valuation Metrics

MGTX Profile

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York.

Price of MGTX

MGTX FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

MGTX Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-1.23
PE Ratio (TTM)
-
Forward PE
1.61
PS Ratio (TTM)
10.50
PB Ratio
225.31
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
94.05%
Net Margin
-140.31%
Revenue Growth (YoY)
144.57%
Profit Growth (YoY)
706.79%
3-Year Revenue Growth
345.03%
3-Year Profit Growth
344.09%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-1.23
PE Ratio (TTM)
-
Forward PE
1.61
PS Ratio (TTM)
10.50
PB Ratio
225.31
Price-to-FCF
-
Gross Margin
94.05%
Net Margin
-140.31%
Revenue Growth (YoY)
144.57%
Profit Growth (YoY)
706.79%
3-Year Revenue Growth
345.03%
3-Year Profit Growth
344.09%
  • When is MGTX's latest earnings report released?

    The most recent financial report for Meiragtx holdings plc (MGTX) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating MGTX's short-term business performance and financial health. For the latest updates on MGTX's earnings releases, visit this page regularly.

  • What is the operating profit of MGTX?

    According to the latest financial report, Meiragtx holdings plc (MGTX) reported an Operating Profit of 26.47M with an Operating Margin of 35.13% this period, representing a growth of 184.06% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is MGTX's revenue growth?

    In the latest financial report, Meiragtx holdings plc (MGTX) announced revenue of 75.36M, with a Year-Over-Year growth rate of 252.33%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does MGTX have?

    As of the end of the reporting period, Meiragtx holdings plc (MGTX) had total debt of 88.69M, with a debt ratio of 0.36. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does MGTX have?

    At the end of the period, Meiragtx holdings plc (MGTX) held Total Cash and Cash Equivalents of 68.19M, accounting for 0.28 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does MGTX go with three margins increasing?

    In the latest report, Meiragtx holdings plc (MGTX) achieved the “three margins increasing” benchmark, with a gross margin of 99.4%%, operating margin of 35.13%%, and net margin of 20%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess MGTX's profit trajectory and future growth potential.

  • Is MGTX's EPS continuing to grow?

    According to the past four quarterly reports, Meiragtx holdings plc (MGTX)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.19. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of MGTX?

    Meiragtx holdings plc (MGTX)'s Free Cash Flow (FCF) for the period is 45.95M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 287.61% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of MGTX?

    The latest valuation data shows Meiragtx holdings plc (MGTX) has a Price-To-Earnings (PE) ratio of -5.77 and a Price/Earnings-To-Growth (PEG) ratio of -0.08. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.